1 story in the last 7 days
The latest cellares news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks cellares across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.

Cathie Wood's ARK Invest invested $20 million in Cellares' Series D, bringing the total round to $277 million. Cellares, founded in 2019, aims to industrialize cell therapy manufacturing with its Cell Shuttle and Cell Q platforms to scale production and reduce costs for patient access.
Summaries by ByteBrief